NCT07484113 IL6-receptor Inhibitor Iwith Belumosudil for the Treatment of Belumosudil-refractory cGVHD Status NOT_YET_RECRUITING Phase PHASE1
NCT07286214 Sarilumab Efficacy and Safety in Adults With Early Polymyalgia Rheumatica Status RECRUITING Phase PHASE4
NCT07154290 A Study to Investigate Ubamatamab With and Without REGN7075 in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) Status RECRUITING Phase PHASE2
NCT06787612 Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer Status RECRUITING Phase PHASE2
NCT05535738 Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT03564340 Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers Status RECRUITING Phase PHASE1/PHASE2
NCT03414502 Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response Status RECRUITING Phase PHASE3